Scalper1 News
Medical-products giant Abbott Laboratories (ABT) agreed on Friday to buy Chilean drugmaker CFR Pharmaceuticals for $2.9 billion. Abbott stock dipped a fraction in heavy trading on the stock market today. The deal, which also involves Abbott’s assumption of $430 million in debt, will add $900 million to Abbott’s 2015 revenue and make it one of the top 10 pharmaceutical companies in Latin America, according to a press release announcing the deal. Scalper1 News
Scalper1 News